NCT04781920 Follow-up of Anterior Cruciate Ligament Reconstruction
| NCT ID | NCT04781920 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Anterior Cruciate Ligament Rupture |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-03-01 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2021-03-01 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Rupture of Anterior Cruciate Ligament (ACL) is a common pathology, but is subject to variability of associated lesions, surgical management and rehabilitation.
Eligibility Criteria
Inclusion Criteria: * Patients having undergone an Anterior Cruciate Ligament (ACL) reconstruction Exclusion Criteria: * None
Contact & Investigator
Thomas NERI, MD
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Saint Etienne
Frequently Asked Questions
Who can join the NCT04781920 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anterior Cruciate Ligament Rupture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04781920 currently recruiting?
Yes, NCT04781920 is actively recruiting participants. Contact the research team at thomas.neri@chu-st-etienne.fr for enrollment information.
Where is the NCT04781920 trial being conducted?
This trial is being conducted at Saint-Etienne, France.
Who is sponsoring the NCT04781920 clinical trial?
NCT04781920 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Thomas NERI, MD at Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 200 participants.